Atomoxetine hydrochloride - Attention Deficit Hyperactivity Disorder (ADHD) - Adults
You are here : Home > Formulary Search > Atomoxetine hydrochloride - Attention Deficit Hyperactivity Disorder (ADHD) - Adults
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Amber
Formulations :
- Capsules
- Oral solution
Formulary Status :
Restrictions / Comments :
Important
Adult ADHD - to be diagnosed, initiated and stabilised on ADHD medication by a SABP specialist before shared-care can be requested.
Patients transitioning from children's services can continue to be managed under existing arrangements
Principles for shared care found here: https://surrey.res.services/PAD/Profile/NonClinicalProfile/9136
Documentation
Guidelines (National)
Information
PAD Profile
ChemicalSubstance :
Atomoxetine hydrochloride
Indication :
Attention Deficit Hyperactivity Disorder (ADHD) - Adults
Group Name :
Keywords :
Attention Deficit Hyperactivity Disorder, shared care
Brand Names Include :
Strattera, Atomaid
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
4
Other Indications
Below are listed other indications that Atomoxetine hydrochloride is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Attention Deficit Hyperactivity Disorder (ADHD) - Adults.
Committee Recommendations (1)
The PCN agreed the Amber Shared Care document below